Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: March 8, 2023
Reporting Period: This filing reports on events occurring on March 8, 2023, specifically regarding upcoming investor presentations.
Key Financial Metrics
This Form 8-K does not contain financial statements, revenue figures, profit data, cash flow, margins, debt levels, or liquidity metrics. The filing serves solely to disclose the use of an investor presentation for upcoming meetings.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing discloses that executive officers intend to use the material in Exhibit 99.2 (Investor Presentation dated March 2023) for upcoming presentations to investors and analysts.
Guidance, Outlook, and Risks
- Management Commentary: The filing references an investor presentation (Exhibit 99.1) but does not include the text of the presentation or specific guidance within the body of this 8-K.
- Regulatory Disclosure: The information provided is furnished pursuant to Item 7.01 (Regulation FD Disclosure) and is not deemed "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless expressly stated.
- Risks and Contingencies: No specific risks or contingencies are detailed in this filing.
Investor Verification Checklist
- Review Exhibit 99.1 (OrthoPediatrics Corp. Investor Presentation dated March 2023) for actual financial data, guidance, and strategic outlook, as this 8-K only references the document.
- Verify the date and content of the upcoming investor presentations mentioned by executive officers.
- Confirm that the information in the referenced presentation is not automatically incorporated by reference into other SEC filings.